Shopping Cart 0
Cart Subtotal
AED 0

UDG Healthcare Plc (UDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities include contract sales outsourcing and related marketing and regulatory services; healthcare logistics based businesses; drug safety monitoring; clinical trial solutions; healthcare communications and events; outsourced packaging solutions for pharmaceutical manufacturers; drug serialization; and nursing services. The company offers its services to biotech and med-tech companies through its network of subsidiaries. The company has operations in the Americas, Europe and Asia. UDG is headquartered in Dublin, Ireland.

UDG Healthcare Plc (UDG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11

Partnerships 13

UDG Healthcare Forms Joint Venture with CMIC 13

Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14

Acquisition 15

Healthcare 21 Acquires Aquilant from H2 Equity 15

UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16

UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17

UDG Healthcare Plc-Key Competitors 18

UDG Healthcare Plc-Key Employees 19

UDG Healthcare Plc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 22

Financial Announcements 22

Aug 03, 2017: UDG Healthcare: Third Quarter Trading Update 22

May 23, 2017: UDG Healthcare: Interim Report 2017 24

Feb 07, 2017: UDG Healthcare: Good start to the year and full year guidance issued 27

Corporate Communications 28

Jan 30, 2018: UDG Healthcare: Directorate Change 28

Dec 19, 2017: UDG healthcare: CFO Appointment 29

Apr 12, 2017: UDG Healthcare appoints Jez Moulding as Group Chief Operating Officer and Executive Vice President of Ashfield 30

Feb 07, 2017: UDG Healthcare: Board appointment 31

Other Significant Developments 32

Jan 30, 2018: UDG Healthcare Announces First Quarter Trading Update 32

Apr 03, 2017: Daiichi Sankyo Announces Sale of Pharmaceutical Packaging Plant in Bethlehem, PA 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11

UDG Healthcare Forms Joint Venture with CMIC 13

Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14

Healthcare 21 Acquires Aquilant from H2 Equity 15

UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16

UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17

UDG Healthcare Plc, Key Competitors 18

UDG Healthcare Plc, Key Employees 19

UDG Healthcare Plc, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

UDG Healthcare Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities include contract sales outsourcing and related marketing and regulatory services; healthcare logistics based businesses; drug safety monitoring; clinical trial solutions; healthcare communications and events; outsourced packaging solutions for pharmaceutical manufacturers; drug serialization; and nursing services. The company offers its services to biotech and med-tech companies through its network of subsidiaries. The company has operations in the Americas, Europe and Asia. UDG is headquartered in Dublin, Ireland.

UDG Healthcare Plc (UDG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11

Partnerships 13

UDG Healthcare Forms Joint Venture with CMIC 13

Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14

Acquisition 15

Healthcare 21 Acquires Aquilant from H2 Equity 15

UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16

UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17

UDG Healthcare Plc-Key Competitors 18

UDG Healthcare Plc-Key Employees 19

UDG Healthcare Plc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 22

Financial Announcements 22

Aug 03, 2017: UDG Healthcare: Third Quarter Trading Update 22

May 23, 2017: UDG Healthcare: Interim Report 2017 24

Feb 07, 2017: UDG Healthcare: Good start to the year and full year guidance issued 27

Corporate Communications 28

Jan 30, 2018: UDG Healthcare: Directorate Change 28

Dec 19, 2017: UDG healthcare: CFO Appointment 29

Apr 12, 2017: UDG Healthcare appoints Jez Moulding as Group Chief Operating Officer and Executive Vice President of Ashfield 30

Feb 07, 2017: UDG Healthcare: Board appointment 31

Other Significant Developments 32

Jan 30, 2018: UDG Healthcare Announces First Quarter Trading Update 32

Apr 03, 2017: Daiichi Sankyo Announces Sale of Pharmaceutical Packaging Plant in Bethlehem, PA 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

UDG Healthcare Plc, Deals By Therapy Area, 2012 to YTD 2018 8

UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9

UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11

UDG Healthcare Forms Joint Venture with CMIC 13

Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14

Healthcare 21 Acquires Aquilant from H2 Equity 15

UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16

UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17

UDG Healthcare Plc, Key Competitors 18

UDG Healthcare Plc, Key Employees 19

UDG Healthcare Plc, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

UDG Healthcare Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.